The National Weather Service issued a report at 9:14 p.m. EDT on Tuesday for strong thunderstorms until 10 p.m. EDT for St.

During a live event, Chandler H. Park, MD, and participants discuss NCCN guidelines and TiNivo-2 data for second-line renal ...

This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...

Gilead Sciences Inc. closed 9.97% short of its 52-week high of $119.96, which the company reached on March 10th.

Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are using these technologies to optimize trial execution.

This milestone follows PharmSight’s recent launch in the U.S. market. With offices in Boston and now Zug, PharmSight is planning expansion into the Middle East and establishing an innovation center ...

The “March of Dissent” rally on Saturday was in response to the lack of abortion access in Texas among other concerns, an ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...

A man who could be facing the death penalty in the death of a Morrow County sheriff’s deputy had his second arraignment ...

In celebration of fathers, the Balm of Gilead Alternative Clinic, in collaboration with the New Tafo PIWC, held the second edition of the Legacy Fathers’ Awards to honour servicemen in Kumasi. The ...

The Impax US Sustainable Economy Fund underperformed the Russell 1000 benchmark in the first quarter. Read more here.